Skip to main content
SpringerLink
Log in

Influenza vaccines: brands differ in reactogenicity

  • Epidemiology clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Petousis-Harris H, Poole T, Turner N, Reynolds G.Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: The importance of routine active safety surveillance. Vaccine 30: 4945-4952, No. 33, 13 Jul 2012. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2012.05.052

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Influenza vaccines: brands differ in reactogenicity. React. Wkly. 1415, 2 (2012). https://doi.org/10.2165/00128415-201214150-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214150-00003

Keywords

Search

Navigation